Haoxi Health Technology Ltd.
13F holders, Q2 2024 (June 30)6holders +4
5new positions
1sold out
$5.32avg. 13F price*
At the end of Q2 2024, 6 institutions reported holding Haoxi Health Technology Ltd. in their 13F filings, up 4 from Q1 2024. 5 opened new positions and 1 sold out. The largest holders were Invesco Ltd. ($66K), HRT Financial LP ($64K) and UBS Group AG ($57K).
- Company
- Haoxi Health Technology Ltd.
- CUSIP
- G4290F100
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $191K |
| Exits | 1 | $18 |
All 13F filers, Q1 2024 → Q2 2024: 46,484 shares bought and 3 shares sold, net +46,481 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Invesco Ltd. | 0.00% | New | 12,285 | $66K |
| HRT Financial LP | 0.00% | New | 12,114 | $64K |
| UBS Group AG | 0.00% | Add +12936.6% | 10,690 | $57K |
| XTX Topco Ltd | 0.00% | New | 10,340 | $55K |
| Royal Bank of Canada | 0.00% | New | 1,132 | $6K |
| Morgan Stanley | 0.00% | New | 5 | $27 |
"% of holder's portfolio" is HAOXI HEALTH TECHNOLOGY LTD's weight in each manager's 13F, not the share of Haoxi Health Technology Ltd. the manager owns.